Companies Dominating the Antinuclear Antibody Test Landscape
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ERBA Diagnostics, Inc.
- Zeus Scientific Inc.
- Trinity Biotech plc
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Immuno Concepts Inc.
- Euroimmun Medizinische Labordiagnostika AG
- Antibodies Incorporated
- Becton, Dickinson and Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Antinuclear Antibody Test Market in 2025 is evaluated at USD 1.42 billion.
The global market size was worth over USD 1.28 billion in 2024 and is poised to grow at a CAGR of around 13.5%, reaching USD 6.64 billion revenue by 2037.
North America is on pace to yield largest share by 2037, driven by growing geriatric population, rising cases of autoimmune diseases, and increasing arthritis prevalence in North America.
The major players in the market include F. Hoffmann-La Roche Ltd., ERBA Diagnostics, Inc., Zeus Scientific Inc., Trinity Biotech plc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Immuno Concepts Inc., Euroimmun Medizinische Labordiagnostika AG, Antibodies Incorporated, Becton, Dickinson and Company.
